United-Guardian, Inc. (NASDAQ:UG) Sees Significant Decline in Short Interest

United-Guardian, Inc. (NASDAQ:UG) saw a significant drop in short interest in October. As of October 15th, there was short interest totaling 7,555 shares, a drop of 39.1% from the September 30th total of 12,413 shares. Currently, 0.2% of the shares of the stock are sold short. Based on an average daily trading volume, of 13,933 shares, the short-interest ratio is currently 0.5 days.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “hold (c)” rating on shares of United-Guardian in a research report on Monday, October 19th. One analyst has rated the stock with a Hold rating. Based on data from MarketBeat, the company has an average rating of “Hold”.

Hedge Funds Weigh In On United-Guardian

Several hedge funds and other institutional investors have recently made changes to their positions in UG. BlackRock Inc. bought a new position in shares of United-Guardian in the second quarter valued at about $105,000. United Capital Financial Advisors LLC bought a new stake in shares of United-Guardian during the 2nd quarter worth about $143,000. Finally, Gamco Investors INC. ET AL boosted its holdings in shares of United-Guardian by 1.2% during the 1st quarter. Gamco Investors INC. ET AL now owns 164,388 shares of the company’s stock worth $1,101,000 after buying an additional 1,888 shares during the period. 23.16% of the stock is owned by institutional investors.

United-Guardian Stock Down 1.0%

NASDAQ UG traded down $0.07 on Tuesday, reaching $7.18. The company had a trading volume of 5,941 shares, compared to its average volume of 7,836. The stock has a market cap of $32.94 million, a price-to-earnings ratio of 13.29 and a beta of 0.95. The stock’s 50 day moving average is $7.05 and its 200-day moving average is $6.95. United-Guardian has a 52 week low of $5.58 and a 52 week high of $8.45.

United-Guardian (NASDAQ:UG) last announced its quarterly earnings results on Friday, August 7th. The company reported $0.16 earnings per share (EPS) for the quarter. United-Guardian had a net margin of 22.01% and a return on equity of 22.24%. The company had revenue of $3.11 million during the quarter.

About United-Guardian

United-Guardian, Inc is a specialty chemicals company that develops, manufactures and markets products for the personal care, pharmaceutical and industrial markets. The company serves customers in the United States and international markets through direct sales, distributors and commercial partners.

Its personal care portfolio includes Lubrajel, a family of water-based moisturizing and lubricating gels used in skin-care, hair-care, cosmetic and personal lubricant formulations. United-Guardian also supplies specialty ingredients designed to improve the texture, moisture retention and performance of finished consumer products.

In the pharmaceutical sector, the company markets Renacidin, a solution used under medical supervision for certain urinary tract applications, including the prevention and dissolution of specific types of urinary encrustations and stones.